The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro and Shortness of Breath — What You Need to Know
Shortness of breath is not listed as a common or very common side effect of Mounjaro (tirzepatide) in UK clinical data, but some people taking this prescription weight management injection have reported it. This guide explains what the evidence shows, when to be concerned, and what you should do if you experience breathlessness while taking Mounjaro. Always speak to your GP if you develop new breathing difficulties.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Is Shortness of Breath a Known Mounjaro Side Effect?
In the clinical trials that led to Mounjaro's UK approval, shortness of breath was not listed as a very common or common side effect. The most frequently reported side effects were gastrointestinal — nausea, diarrhoea, vomiting, and constipation. However, individual experiences vary, and some people taking tirzepatide have reported breathlessness.
Shortness of breath is occasionally recorded as an uncommon side effect in broader safety monitoring. If this occurs, it may relate to several factors: gradual weight management itself (which can affect cardiovascular stress), dehydration from gastrointestinal symptoms, or underlying conditions becoming more apparent as weight changes. When comparing Mounjaro versus Wegovy (semaglutide), both medications can theoretically cause similar less common side effects, though direct data comparing them is limited.
Your prescriber will assess your individual health history, including any respiratory or heart conditions, before initiating Mounjaro dose titration, which helps minimise unexpected reactions.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
When to Seek Medical Advice
Contact your GP urgently if you experience sudden, severe, or worsening shortness of breath, chest pain, or difficulty breathing that affects your daily activities. These could indicate a serious condition unrelated to Mounjaro itself — such as a cardiovascular event, infection, or lung problem — that requires immediate medical assessment.
Mild breathlessness that appears after starting Mounjaro and gradually improves may be less urgent, but still warrants a GP discussion within a few days. Your GP can determine whether it's related to the medication, gradual weight management, or another cause. Do not stop taking Mounjaro without medical guidance, as your prescriber needs to know about any new symptoms to adjust your Mounjaro UK prescription appropriately.
Keep a brief symptom log if breathlessness occurs — noting when it happens, how long it lasts, and any triggers — to help your GP make an informed decision.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is shortness of breath listed as a common side effect of Mounjaro?
No. Shortness of breath is not listed as a very common or common side effect in the UK clinical trial data for Mounjaro (tirzepatide). The most common side effects are gastrointestinal — nausea, diarrhoea, and constipation. However, it may occasionally occur and should always be reported to your GP.
Could shortness of breath be related to weight loss itself rather than Mounjaro?
Yes, possibly. gradual weight management can temporarily affect cardiovascular function and oxygen demands. Additionally, dehydration from Mounjaro-related nausea or diarrhoea may contribute to breathlessness. Your GP can investigate whether the symptom is medication-related or linked to other factors.
Should I stop taking Mounjaro if I experience shortness of breath?
Do not stop without consulting your GP first. While breathlessness warrants urgent assessment, your prescriber needs to know about the symptom to decide whether to continue, adjust your dose, or investigate further. Stopping suddenly without guidance may not be appropriate.
How does Mounjaro compare to Wegovy if I'm concerned about breathing issues?
Both Mounjaro and Wegovy are GLP-1-based weight management injections with similar uncommon side effect profiles. Neither lists shortness of breath as a common side effect. Any respiratory concerns should be discussed with your prescriber before starting either medication, not used to choose between them.
What should I mention to my GP about shortness of breath and Mounjaro?
Tell your GP when the breathlessness started (before or after Mounjaro), how severe it is, whether it's constant or comes and goes, any other symptoms, and your medical history — especially previous heart, lung, or breathing conditions. This helps your GP assess whether Mounjaro eligibility UK criteria were appropriate for you.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.